SCHEMBL5638259

SCHEMBL5638259

Cc1cccc(N)c1S(C)(=O)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD44 P16070 1/20 0.48
CYP3A4 P08684 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
TSHR P16473 1/20 0.42
PIK3CA P42336 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.39
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
DPP4 P27487 1/20 0.37
GAA P10253 4/20 0.37
MEN1 O00255 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
ALDH1A1 P00352 3/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CYP2C9 P11712 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11205012 0.86 CYP3A4 (0.43) CD44CYP3A4TDP1TSHRPIK3CA
SCHEMBL4158892 0.84 KEAP1 (0.45) TDP1TSHRL3MBTL1KEAP1NFE2L2
SCHEMBL1523492 0.83 CD44 (0.48) CD44CYP3A4TDP1TSHRPIK3CA
SCHEMBL28506091 0.83 CD44 (0.48) CD44CYP3A4TDP1TSHRPIK3CA
SCHEMBL615250 0.81 CD44 (0.46) CD44CYP3A4TDP1TSHRPIK3CA
SCHEMBL21235172 0.79 CD44 (0.45) CD44CYP3A4TDP1TSHRPIK3CA
Hydrochloric Acid SCHEMBL11803726 0.79 TDP1 (0.46) CD44CYP3A4TDP1TSHRPIK3CA
SCHEMBL7211351 0.78 GAA (0.46) CD44CYP3A4TDP1TSHRPIK3CA
SCHEMBL31672192 0.78 GAA (0.46) CD44CYP3A4TDP1TSHRPIK3CA
SCHEMBL11869206 0.77 TSHR (0.44) CYP3A4TSHRPIK3CAGAACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110092759-A The chloro- 2,4- pyrimidine derivatives of 5- as anti-tumor drug 陆柯潮 2019-08-06 CN disclosed
CN-102459258-A Preparation and use of 1,2, 4-triazolo [1,5a ] pyridine derivatives CEPHALON INC 2012-05-16 CN disclosed
US-7196229-B2 Benzoylcyclohexenone derivatives BASF AKTIENGESELLSCHAFT (DE) 2007-03-27 US disclosed
US-20040235793-A1 Benzoylcyclohexenone derivatives BASF AKTIENGESELLSCHAFT (DE) 2004-11-25 US disclosed
EP-1417170-A1 BENZOYLCYCLOHEXENONE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2004-05-12 EP disclosed
WO-2003014071-A1 BENZOYLCYCLOHEXENONE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2003-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235793-A1 Benzoylcyclohexenone derivatives CYC1, CYP1B1, CYP1A1 CD44 4850/4885CYP3A4 156/4885TDP1 1437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.